PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ AGONIST ATTENUATES ALCOHOL-INDUCED HEPATIC INSULIN RESISTANCE AND IMPROVES LIVER INJURY AND REPAIR

被引:0
|
作者
Pang, Maoyin [1 ,2 ]
de la Monte, Suzanne [1 ,3 ]
He, Jiman [1 ,2 ]
Chaudhry, Rajeeve [1 ,2 ]
Duan, Kevin [1 ,2 ]
Ouh, Jiyun [1 ,2 ]
Wands, Jack R. [1 ,2 ]
机构
[1] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA
[2] Rhode Isl Hosp, Dept Med, Liver Res Ctr, Providence, RI 02903 USA
[3] Rhode Isl Hosp, Dept Pathol & Med, Providence, RI USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
335
引用
收藏
页码:460A / 460A
页数:1
相关论文
共 50 条
  • [41] Peroxisome proliferator-activated receptor in liver diseases.
    赵彩彦
    姜玲玲
    中华肝脏病杂志, 2003, (06) : 63 - 65
  • [42] Peroxisome proliferator-activated receptor delta and liver diseases
    Yamazaki, Tomoo
    Cable, Edward E.
    Schnabl, Bernd
    HEPATOLOGY COMMUNICATIONS, 2025, 9 (02)
  • [43] The expression of peroxisome proliferator-activated receptor-α in rats with alcoholic liver injury
    Long, S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 154 - 154
  • [44] Caffeic acid improves skin barrier function as Peroxisome proliferator-activated receptor (PPAR)-α agonist
    Oh, M.
    Kim, J.
    Lee, S.
    Kim, B.
    Kim, H.
    Kim, S.
    Chang, B.
    Lee, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S51 - S51
  • [45] Increased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor δ from Peroxisome proliferator-activated receptor γ in the ob/obmouse
    Lee D Roberts
    David G Hassall
    Deborah A Winegar
    John N Haselden
    Andrew W Nicholls
    Julian L Griffin
    Genome Medicine, 1
  • [46] CIS-DICHLORODIAMMINEPLATINUM UPREGULATES THE EXPRESSION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ AND ENHANCES THE CYTOTOXICITY OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ AGONIST
    Tanaka, Nobuyuki
    Miyajima, Akira
    Hasegawa, Masanori
    Shirotake, Suguru
    Kosaka, Takeo
    Kikuchi, Eiji
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2010, 183 (04): : E379 - E379
  • [47] Importance of peroxisome proliferator-activated receptor-γ in hepatic ischemia/reperfusion injury in mice
    Akahori, Takahiro
    Sho, Masayuki
    Hamada, Kaoru
    Suzaki, Yasue
    Kuzumoto, Yukiyasu
    Nomi, Takeo
    Nakamura, Shinji
    Enomoto, Koji
    Kanehiro, Hiromichi
    Nakajima, Yoshiyuki
    JOURNAL OF HEPATOLOGY, 2007, 47 (06) : 784 - 792
  • [48] Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates acrolein-induced airway mucus hypersecretion in rats
    Liu, Dai-Shun
    Liu, Wei-Jia
    Chen, Lei
    Ou, Xue-Mei
    Wang, Tao
    Feng, Yu-Lin
    Zhang, Shang-Fu
    Xu, Dan
    Chen, Ya-Juan
    Wen, Fu-Qiang
    TOXICOLOGY, 2009, 260 (1-3) : 112 - 119
  • [49] Peroxisome proliferator-activated receptor α agonist-induced histidine decarboxylase gene expression in the rat and mouse liver
    Amagase, Yoko
    Mizukawa, Yumiko
    Urushidani, Tetsuro
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2020, 45 (08): : 475 - 492
  • [50] Role of Peroxisome Proliferator-activated Receptor δ/β in Hepatic Metabolic Regulation
    Liu, Sihao
    Hatano, Ben
    Zhao, Minghui
    Yen, Chen-Chung
    Kang, Kihwa
    Reilly, Shannon M.
    Gangl, Matthew R.
    Gorgun, Cem
    Balschi, James A.
    Ntambi, James M.
    Lee, Chih-Hao
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (02) : 1237 - 1247